Literature DB >> 28088737

The hemostatic effect study of Cirsium setosum on regulating α1-ARs via mediating norepinephrine synthesis by enzyme catalysis.

Nianwei Chang1, Yanmei Li2, Mengge Zhou2, Jie Gao2, Yuanyuan Hou2, Min Jiang3, Gang Bai4.   

Abstract

BACKGROUND: Cirsium setosum (CS) is the aboveground part of Cephalanoplos segetum Kitam. Although it has been used as a hemostatic treatment for thousands of years and is still in use today, the mechanism of CS on regulating ARs is still not clear.
PURPOSE: In this study, we aimed to clarify the mechanism of CS on regulating ARs.
METHODS: We developed a simple method based on UPLC/Q-TOF MS combined adrenergic receptor dual-luciferase reporter assay systems for the rapid determination of active constituents in CS. The mechanism of tyramine, the main active component for regulating ARs, was further investigated by an in vitro norepinephrine biotransformation test and in vivo vaso activity tests.
RESULTS: Two phenethylamine ARs regulators (tyramine and N-methyltyramine) in CS were characterized, and it was found that tyramine could induce vasoconstriction via regulation of α1-ARs by mediating norepinephrine synthesis.
CONCLUSION: The hemostatic effect of CS is associated with tyramine and N-methyltyramine, via regulation of α1-ARs, and the mechanism of tyramine is related to mediating norepinephrine synthesis by enzyme catalysis.
Copyright © 2017. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Adrenergic receptor; Cirsium setosum; Norepinephrine; Tyramine

Mesh:

Substances:

Year:  2017        PMID: 28088737     DOI: 10.1016/j.biopha.2017.01.022

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  1 in total

1.  Comparison of the Hepatoprotective Effects of Four Endemic Cirsium Species Extracts from Taiwan on CCl₄-Induced Acute Liver Damage in C57BL/6 Mice.

Authors:  Zi-Wei Zhao; Jen-Chih Chang; Li-Wei Lin; Fan-Hsuan Tsai; Hung-Chi Chang; Chi-Rei Wu
Journal:  Int J Mol Sci       Date:  2018-04-30       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.